Abstract
Yeast acquisition begins at birth; however, the contribution of the mother on yeast transmission to the offspring and associated resistance is yet to be clarified. The aim of this study was to explore the vertical transmission of yeasts and their antifungal susceptibility profile in early life. Oral, fecal, and breastmilk samples were collected from 73 mother–child pairs four to twelve weeks after delivery and cultured on Sabouraud dextrose agar with chloramphenicol. The isolates were identified by MALDI-TOF MS. The vertical transmission was studied by microsatellite genotyping. Antifungal susceptibility was determined for fluconazole, voriconazole, miconazole, anidulafungin, and nystatin by broth microdilution assay, following CLSI–M60 guidelines. A total of 129 isolates were identified from 53% mother–child pairs. We verified the vertical transmission of Candida albicans (n = three mother–child pairs) and Candida parapsilosis (n = one mother–child pair) strains, including an antifungal resistant strain transmitted from breastmilk to the gut of a child. Most isolates were susceptible to the tested antifungals, with the exception of four C. albicans isolates and one R. mucilaginosa isolate. The vertical transmission of yeasts happens in early life. This is the first work that demonstrated the role of the mother as a source of transmission of antifungal-resistant yeasts to the child.
| Original language | English |
|---|---|
| Article number | 1449 |
| Pages (from-to) | 1-13 |
| Number of pages | 13 |
| Journal | International Journal of Molecular Sciences |
| Volume | 24 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2 Jan 2023 |
Bibliographical note
This article belongs to the Special Issue Candidaemia.Published online: 11 January 2023.
Publisher Copyright:
© 2023 by the authors.
Funding
This research was funded by BIOCODEX (Biocodex National Call 2021–Portugal), by a Research Grant 2021 from the European Society of Clinical Microbiology and Infectious Diseases (ESCMIDs) to M.J.A., and by national funds through Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT) within the scope of UIDB/04423/2020, UIDP/04423/2020 (Group of Natural Products and Medicinal Chemistry-CIIMAR–E.P.). M.J.A.’s Ph.D. fellowship was supported by an FCT scholarship (SFRH/BD/144982/2019). R.A. was supported by Individual Call to Scientific Employment Stimulus—Second Edition (grant number CEECIND/01070/2018). J.C.’s post-doc research contract was funded by FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the COMPETE 2020—POCI (Operational Program for Competitiveness and Internationalization) Portugal 2020, and by Portuguese funds through FCT/MCTES in the framework of the project MicroMOB (POCI-01-0145-FEDER-029777/PTDC/MEC-MCI/29777/2017). A.F.F.’s Ph.D. fellowship was supported by an FCT scholarship (SFRH/BD/138925/2018).
| Funders | Funder number |
|---|---|
| Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior | |
| Programa Operacional Temático Factores de Competitividade | |
| European Regional Development Fund | |
| European Society of Clinical Microbiology and Infectious Diseases | |
| Fundação para a Ciência e a Tecnologia | CEECIND/01070/2018, UIDP/04423/2020, SFRH/BD/144982/2019, SFRH/BD/138925/2018 |
| Ministério da Ciência, Tecnologia e Ensino Superior | POCI-01-0145-FEDER-029777/PTDC/MEC-MCI/29777/2017 |
Keywords
- antifungal susceptibility
- mother–child fungal transmission
- opportunistic/pathogenic fungi